Bertrand Jaber MD, MSc, FASN, FNKF
Adjunct Professor, General Internal Medicine
72 E. Concord Street | (617) 562-7405bjaber@bu.edu
Sections
General Internal Medicine
Biography
Dr. Jaber is the Chair of Medicine and a board-certified internist and nephrologist. He serves as Chair of the Clinical Competency Committee, and Core Faculty for the Internal Medicine Residency Program. Dr. Jaber received his medical degree from St. Joseph University Faculty of Medicine, Beirut, Lebanon, and completed a residency in Internal Medicine at Carney Hospital, Boston, MA, followed by a clinical and research fellowship in nephrology at Tufts New England Medical Center, Boston, MA. He also holds a Master of Science in Clinical Research from the Graduate School of Biomedical Sciences at Tufts University.
Dr. Jaber has had a longstanding commitment to medical education. Over the years, he has been the recipient of numerous teaching awards and citations from medical students and residents, including the St. Luke’s Award in recognition of his dedication and excellence to the education of residents. Dr. Jaber is a member of the Intern Selection Committee and participates extensively in lecture instructions and in hospital- and clinic-based teaching of residents. He also directs the Quality Improvement Curriculum of the residency program.
Dr. Jaber’s research interests and original accomplishments have covered several important areas within the field of nephrology, including biocompatibility of dialyzers, leukocyte dysfunction in uremia, novel dialysis therapies, and the utility of biomarkers in acute kidney injury. He has also made contributions to the field of evidence-based medicine through the conduct of meta-analyses on the prevention and treatment of kidney diseases. He has mentored and supervised scores of trainees through the conduct of quality improvement initiatives and research projects.
Education
MD, St. Joseph's University
Biomedical Sciences, MSc, Tufts University
BS, Collège Mont La Salle
Publications
Alabdul Razzak I, Korchemny N, Smoot D, Jose A, Jones A, Price LL, Jaber BL, Moraco AH. Parameters Predictive of Propofol-Associated Acute Pancreatitis in Critically Ill Patients with COVID-19 Pneumonia: A Retrospective Cohort Study. J Intensive Care Med. 2024 Jul 23; 8850666241265671. PMID: 39043370.
Published on 6/7/2024Philipp M, Tessier A, Donnelly M, Fang L, Feng K, Zhao L, Grosser S, Sun G, Sun W, Mentré F, Bertrand J. Model-based bioequivalence approach for sparse pharmacokinetic bioequivalence studies: Model selection or model averaging? Stat Med. 2024 Aug 15; 43(18):3403-3416. PMID: 38847215.
Published on 6/6/2024Guhl M, Bertrand J, Fayette L, Mercier F, Comets E. Correction: Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models-a New Method Based on Metropolis-Hastings Algorithm. AAPS J. 2024 Jun 06; 26(4):64. PMID: 38844645.
Published on 6/5/2024Baudemont G, Tardivon C, Monneret G, Cour M, Rimmelé T, Garnier L, Yonis H, Richard JC, Coudereau R, Gossez M, Wallet F, Delignette MC, Dailler F, Buisson M, Lukaszewicz AC, Argaud L, Laouenan C, Bertrand J, Venet F. Joint modeling of monocyte HLA-DR expression trajectories predicts 28-day mortality in severe SARS-CoV-2 patients. CPT Pharmacometrics Syst Pharmacol. 2024 Jul; 13(7):1130-1143. PMID: 38837680.
Published on 5/16/2024Vázquez K, Moreno-Rodríguez A, Domínguez-Díaz LR, Bertrand J, Salas CO, Rivera G, Pérez Cervera Y, Bocanegra-García V. In vitro and In vivo Biological Activity of Two Aryloxy-naphthoquinones in Mice Infected with Trypanosoma cruzi Strains. Med Chem. 2024 May 16. PMID: 38757318.
Published on 5/11/2024Stücker S, Koßlowski F, Buchholz A, Lohmann CH, Bertrand J. High frequency of BCP, but less CPP crystal-mediated calcification in cartilage and synovial membrane of osteoarthritis patients. Osteoarthritis Cartilage. 2024 May 11. PMID: 38735362.
Published on 5/11/2024Delgado T, Veselá D, Dostálová H, Kryštof V, Vojácková V, Jorda R, Castro A, Bertrand J, Rivera G, Faúndez M, Strnad M, Espinosa-Bustos C, Salas CO. New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs. Pharmaceutics. 2024 May 11; 16(5). PMID: 38794311.
Published on 4/23/2024Guhl M, Bertrand J, Fayette L, Mercier F, Comets E. Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models-a New Method Based on Metropolis-Hastings Algorithm. AAPS J. 2024 Apr 23; 26(3):53. PMID: 38722435.
Published on 3/27/2024Bergmann M, Fakhoury B, Barroso T, Prushik SG, Jaber BL, Balakrishnan VS. Early access flow rate predicts vascular access patency-related intervention in the first year: A retrospective cohort study. Hemodial Int. 2024 Jul; 28(3):262-269. PMID: 38533534.
Published on 2/11/2024Phillips T, Mughrabi A, Garcia LJ, El Mouhayyar C, Hattar L, Tighiouart H, Moraco AH, Nader C, Jaber BL. Association of Body Mass Index with Multiple Organ Failure in Hospitalized Patients with COVID-19: A Multicenter Retrospective Cohort Study. J Intensive Care Med. 2024 Aug; 39(8):768-777. PMID: 38343031.